A multi-institutional evaluation of active surveillance for low risk prostate cancer Academic Article uri icon

Overview

MeSH Major

  • Prostatic Neoplasms
  • Watchful Waiting

abstract

  • With a median followup of 29 months active surveillance for select patients appears to be safe and associated with a low risk of systemic progression. Cancer at restaging biopsy and a higher total number of cancerous cores are associated with a lower likelihood of remaining on active surveillance. A restaging biopsy should be strongly considered to finalize eligibility for active surveillance.

publication date

  • January 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.juro.2012.11.023

PubMed ID

  • 23234624

Additional Document Info

start page

  • S19

end page

  • 25; discussion S25

volume

  • 189

number

  • 1 SUPPL